QUININE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Quinine, and what generic alternatives are available?
Quinine is a drug marketed by Amneal Pharms, Aurobindo Pharma Usa, Ingenus Pharms Llc, Lupin, and Teva Pharms. and is included in five NDAs.
The generic ingredient in QUININE is quinine sulfate. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the quinine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quinine
A generic version of QUININE was approved as quinine sulfate by TEVA PHARMS on September 28th, 2012.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for QUININE?
- What are the global sales for QUININE?
- What is Average Wholesale Price for QUININE?
Summary for QUININE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Drug Prices: | Drug price information for QUININE |
| DailyMed Link: | QUININE at DailyMed |
US Patents and Regulatory Information for QUININE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms | QUININE SULFATE | quinine sulfate | CAPSULE;ORAL | 203729-001 | Jul 15, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Lupin | QUININE SULFATE | quinine sulfate | CAPSULE;ORAL | 203112-001 | Apr 24, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Aurobindo Pharma Usa | QUININE SULFATE | quinine sulfate | CAPSULE;ORAL | 202581-001 | Dec 14, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ingenus Pharms Llc | QUININE SULFATE | quinine sulfate | CAPSULE;ORAL | 204372-001 | Jul 22, 2015 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva Pharms | QUININE SULFATE | quinine sulfate | CAPSULE;ORAL | 091661-001 | Sep 28, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
